Snehal Patel - Dec 24, 2024 Form 4 Insider Report for Greenwich LifeSciences, Inc. (GLSI)

Role
CEO and CFO, Director, 10%+ Owner
Signature
/s/ Snehal Patel
Stock symbol
GLSI
Transactions as of
Dec 24, 2024
Transactions value $
$0
Form type
4
Date filed
12/27/2024, 04:19 PM
Previous filing
Sep 30, 2024
Next filing
Jan 2, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLSI Stock Options Award $0 +1.15M +106.98% $0.00 2.22M Dec 24, 2024 Common Stock 1.15M $12.16 Direct F1
transaction GLSI Stock Options Award $0 +25K +1.13% $0.00 2.25M Dec 24, 2024 Common Stock 25K $12.16 By Wife F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 262,181 options are earned upon date of grant and 786,542 options are earned monthly over 36 months. 10% of the earned options vest if reporting person has been employed by Issuer between 1-2 years from grant date, 20% of the earned options vest if reporting person has been employed by Issuer between 2-3 years from grant date, 30% of the earned options vest if reporting person has been employed by Issuer between 3-4 years from grant date and the remaining earned options vest if reporting person has been employed by Issuer more than 4 years after grant date. 100,000 options are earned and vest upon date of grant.
F2 6,252 options are earned and vest upon date of grant and the remainder are earned and vest monthly over 36 months.